Hot Topics: Depression in Individuals With Psoriasis and Psoriatic Arthritis

被引:1
作者
Goel, Niti [1 ,2 ]
Wallace, Elizabeth B. [3 ]
Lindsay, Christine [4 ]
机构
[1] Duke Univ Sch Med, Caduceus Biomed Consulting LLC, Durham, NC USA
[2] Duke Univ Sch Med, Dept Med, Div Rheumatol, Durham, NC USA
[3] Cherry Hills Dermatol, Englewood, CO USA
[4] Patient Res Partner, Prosper, TX USA
关键词
comorbidity; depression; GRAPPA; psoriasis; psoriatic arthritis; PATIENT-REPORTED OUTCOMES; SEVERE PLAQUE PSORIASIS; QUALITY-OF-LIFE; ORAL PHOSPHODIESTERASE-4 INHIBITOR; TO-SEVERE PSORIASIS; PHASE-III; DOUBLE-BLIND; NAIVE PATIENTS; MODERATE; PLACEBO;
D O I
10.3899/jrheum.2024-0362
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Psoriasis and psoriatic arthritis are associated with an increased risk of mental health conditions such as depression and anxiety. People with psoriatic disease (PsD) are also more likely to die by suicide than those without. Mood disorders affect people with PsD in a multitude of ways, such as in effectiveness of care, response to treatment, remission rates, and quality of life. Although the links between PsD and mental health conditions have not been fully elucidated, this review will highlight recent studies investigating shared biologic mechanisms between depression and PsD. Since mental health disorders can be assessed and treated effectively, dermatologists and rheumatologists should be aware of the mental health burden in individuals with PsD to accomplish the following: (1) educate their patients with PsD about this association, (2) screen for mental health conditions on an ongoing basis in their clinical practice, (3) refer their patients with PsD to a mental health professional when needed, and (4) ensure selection of a safe PsD treatment in the setting of comorbid mental health disease. Finally, important treatment considerations for individuals with PsD and depression are reviewed. This topic was presented at the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) 2023 annual meeting.
引用
收藏
页码:43 / 50
页数:8
相关论文
共 50 条
  • [21] Power of crowdsourcing: Novel methods of data collection in psoriasis and psoriatic arthritis
    Armstrong, April W.
    Harskamp, Caitlin T.
    Cheeney, Safia
    Wu, Julie
    Schupp, Clayton W.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2012, 67 (06) : 1273 - U278
  • [22] Prevalence of psoriatic arthritis in patients with psoriasis: A systematic review and meta-analysis of observational and clinical studies
    Alinaghi, Farzad
    Calov, Monika
    Kristensen, Lars Erik
    Gladman, Dafna D.
    Coates, Laura C.
    Jullien, Denis
    Gottlieb, Alice B.
    Gisondi, Paolo
    Wu, Jashin J.
    Thyssen, Jacob P.
    Egeberg, Alexander
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 80 (01) : 251 - +
  • [23] An update on the impact of depression on the treatment of psoriasis
    Bell, Katheryn
    Balogh, Esther A.
    Feldman, Steven R.
    EXPERT OPINION ON PHARMACOTHERAPY, 2021, 22 (06) : 695 - 703
  • [24] Quo vadis, biological treatment for psoriasis and psoriatic arthritis?
    Olszewska, Barbara
    Adamski, Zygmunt
    Czarnecka-Operacz, Magdalena
    POSTEPY DERMATOLOGII I ALERGOLOGII, 2018, 35 (03): : 231 - 237
  • [25] Apremilast: A Novel Oral Treatment for Psoriasis and Psoriatic Arthritis
    Torres, Tiago
    Puig, Luis
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2018, 19 (01) : 23 - 32
  • [26] Psoriatic arthritis: Current topics
    McCarey D.
    McInnes I.B.
    Current Rheumatology Reports, 2007, 9 (6) : 442 - 448
  • [27] Identification of Psoriatic Arthritis in Patients With Psoriasis
    Coates, Laura C.
    Eder, Lihi
    Poddubnyy, Denis
    Rosen, Cheryl F.
    JOURNAL OF RHEUMATOLOGY, 2023, 50 (11) : 25 - 26
  • [28] Combination Therapy of Apremilast and Biologic Agent as a Safe Option of Psoriatic Arthritis and Psoriasis
    Metyas, Samy
    Tomassian, Christopher
    Messiah, Ramy
    Gettas, Tina
    Chen, Christina
    Quismorio, Anne
    CURRENT RHEUMATOLOGY REVIEWS, 2019, 15 (03) : 234 - 237
  • [29] New biologics for psoriasis and psoriatic arthritis
    Rozenblit, Mariya
    Lebwohl, Mark
    DERMATOLOGIC THERAPY, 2009, 22 (01) : 56 - 60
  • [30] Outcome Measures in Psoriasis and Psoriatic Arthritis
    Kim N.
    Gottlieb A.B.
    Current Dermatology Reports, 2013, 2 (3) : 159 - 163